DIN 02555239 — ZYNYZ 25 MG
ZYNYZ is a solution of Retifanlimab marketed by INCYTE CORPORATION. The full Retifanlimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02555239
- Brand name
- ZYNYZ
- Active ingredient
- Retifanlimab
- Strength
- 25 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- INCYTE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- PD-1 immune checkpoint inhibitor (anti-PD-1 monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.